Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial

Peter J. Goadsby, David W. Dodick, Jessica Ailani, Joel M. Trugman, Michelle Finnegan, Kaifeng Lu, Armin Szegedi

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences